Financial Architects (New Jersey)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-87
| Closed | -$21K | – | 921 |
|
|
2020
Q1 | $21K | Buy |
+87
| New | +$21K | 0.01% | 505 |
|
|
2019
Q2 | – | Sell |
-137
| Closed | -$25K | – | 1336 |
|
|
2019
Q1 | $25K | Hold |
137
| – | – | ﹤0.01% | 728 |
|
|
2018
Q4 | $23K | Sell |
137
-40
| -23% | -$6.72K | ﹤0.01% | 692 |
|
|
2018
Q3 | $34K | Sell |
177
-81
| -31% | -$15.6K | 0.01% | 656 |
|
|
2018
Q2 | $44K | Buy |
258
+119
| +86% | +$20.3K | 0.01% | 602 |
|
|
2018
Q1 | $23K | Buy |
139
+21
| +18% | +$3.48K | ﹤0.01% | 745 |
|
|
2017
Q4 | $18K | Hold |
118
| – | – | ﹤0.01% | 873 |
|
|
2017
Q3 | $18K | Sell |
118
-213
| -64% | -$32.5K | ﹤0.01% | 883 |
|
|
2017
Q2 | $43K | Sell |
331
-16
| -5% | -$2.08K | 0.01% | 638 |
|
|
2017
Q1 | $38K | Buy |
347
+12
| +4% | +$1.31K | 0.01% | 667 |
|
|
2016
Q4 | $24K | Buy |
335
+99
| +42% | +$7.09K | 0.01% | 791 |
|
|
2016
Q3 | $21K | Buy |
236
+179
| +314% | +$15.9K | 0.01% | 827 |
|
|
2016
Q2 | $5K | Buy |
57
+35
| +159% | +$3.07K | ﹤0.01% | 1115 |
|
|
2016
Q1 | $2K | Buy |
+22
| New | +$2K | ﹤0.01% | 1051 |
|
|
2015
Q3 | – | Sell |
-129
| Closed | -$16K | – | 889 |
|
|
2015
Q2 | $16K | Hold |
129
| – | – | 0.01% | 672 |
|
|
2015
Q1 | $15K | Hold |
129
| – | – | 0.01% | 632 |
|
|
2014
Q4 | $15K | Buy |
129
+96
| +291% | +$11.2K | 0.01% | 586 |
|
|
2014
Q3 | $4K | Buy |
+33
| New | +$4K | ﹤0.01% | 764 |
|